Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, FVIII intolerance and uveitis. Headquartered in Chepstow, Wales, with laboratories in Belgium, Apitope’s mission is to develop novel therapeutics that directly target the underlying cause of allergy and autoimmune disease.
CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercialising simple drug delivery devices that can be easily integrated into daily life. The company’s lead product, PAQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. CeQur has offices in Boston and Switzerland and also operates from the Life Sciences Hub in Wales.
Interrad Medical is committed to the development and commercialisation of innovative medical devices for use in minimally invasive interventional and surgical procedures. The company’s first product is the SecurAcath – a revolutionary device which makes it possible to hold virtually any catheter securely in place without sutures or adhesives. Based in the US, its European headquarters are based in Cardiff.
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, the company has headquarters in Cardiff, UK and Georgia, USA, and its customers are some of the world’s leading medical institutions.
Proton Partners International Ltd
Proton Partners International Ltd is a company committed to providing innovative cancer care by bringing high energy proton beam therapy to the UK. The company is building oncology centres across the UK, which will be known as The Rutherford Cancer Centres, and will offer proton beam therapy, radiotherapy, chemotherapy, imaging and wellbeing services. Its first site is based in Newport, South Wales.
ReNeuron is a leading, clinical-stage cell therapy development company. Based in the Bridgend, its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need. ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional immunosuppressive drug treatments.
Simbec-Orion Group offers specialist expertise in oncology, rare & orphan diseases, respiratory, dermatology and infectious vaccines & diseases. Simbec-Orion Group provide clients with a full spectrum of drug development services from first-in-human Phase I clinical studies through to pivotal Phase III studies and Phase IV post marketing studies. Simbec-Orion have expertise in all drug types, dosage forms and delivery mechanisms and is headquartered in Merthyr Tydfil.
Sphere Medical plc
Sphere Medical is a dynamic company specialising in the development of innovative medical monitoring and diagnostic equipment. The company’s products are used in a wide range of medical applications, enabling faster clinical decision-making and improved patient outcomes, whilst providing efficiencies that result in reduced healthcare costs. With R&D and other operations in Cambridge, Sphere recently opened its manufacturing facility in St Asaph, N Wales.
Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialisation of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD and cystic fibrosis. Verona Pharma has offices in Cardiff and is listed on the London Stock Exchange and is supported by a number of large, specialist healthcare focused investors from the UK, Europe and the US.